Comparison of the efficacy in prevention of hepatitis B virus recurrence after liver transplantation between HBIG and lamivudine.
Lee
K W
KW
Department of Surgery, Samsung Medical Center, Sungkyunkwan University, School of Medicine, Seoul, South Korea.
Lee
S K
SK
Joh
J W
JW
Kim
S J
SJ
Park
J H
JH
Chon
S E
SE
Choi
S H
SH
Heo
J S
JS
Paik
S W
SW
Koh
K W
KW
Lee
J H
JH
Choi
M S
MS
Kim
Y I
YI
Lee
B B
BB
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006509:Hepatitis B / Q000517:prevention & control*; D006801:Humans; D007116:Immunization, Passive; D007136:Immunoglobulins / Q000627:therapeutic use*; D019259:Lamivudine / Q000627:therapeutic use*; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000517:prevention & control / Q000821:virology; D012008:Recurrence; D013997:Time Factors
D000998:Antiviral Agents; D007136:Immunoglobulins; D019259:Lamivudine; C045213:hepatitis B hyperimmune globulin